What’s Next for Specialty Medication Benefit Design and Reimbursement
Current inefficiencies in the health care system create administrative burdens for patients, providers, and payers, and often result in additional unnecessary costs. As a result, the government and private sectors are examining new reimbursement and benefit designs to pay for medications, including re-examining the Medicare Part B and Medicaid programs. Before implementing major changes, however, stakeholders must carefully analyze the potential impact these reforms will have on patient care, access to medications, and the overall health care system. In the forum participants made recommendations and considered ways that benefited design and reimbursement without compromising patient access and care.